Typical Liver Function Tests in Autoimmune Hepatitis
Autoimmune hepatitis characteristically presents with elevated aminotransferases (AST and ALT), elevated serum IgG or gamma-globulin levels (>1.5× upper limit of normal in most cases), and an alkaline phosphatase to AST ratio <1.5, though approximately 15-39% of patients may have normal IgG levels, particularly in acute presentations. 1, 2
Primary Biochemical Pattern
Aminotransferase Elevation
- AST and ALT are typically elevated 5-20 times the upper limit of normal in most AIH presentations 1
- The pattern is predominantly hepatocellular rather than cholestatic 1
- In acute presentations, AST and ALT may exceed 400 IU/mL 1
- An AST/ALT ratio >1.5 or ALT >5× ULN with positive autoantibodies strongly suggests AIH 2
Alkaline Phosphatase Pattern
- **ALP/AST ratio <1.5 supports AIH diagnosis**, while a ratio >3 argues against it 1, 3
- ALP elevation is typically mild to moderate compared to the aminotransferase elevation 1
- If a cholestatic pattern (elevated ALP) is present, consider AIH-PBC or AIH-PSC overlap syndromes and perform AMA testing and cholangiography 1
Immunoglobulin and Protein Abnormalities
IgG and Gamma-Globulin Elevation
- Approximately 85% of AIH patients have elevated serum IgG or gamma-globulin levels (>1.5× ULN in definite cases) 2, 3
- Hypergammaglobulinemia is polyclonal and represents a central diagnostic element 2
- Selective elevation of IgG without IgA and IgM elevation is particularly suggestive of AIH 2
Important Caveat About Normal Globulins
- 15-39% of AIH patients present with normal IgG/globulin levels, particularly in acute-onset disease 2, 3
- In acute presentations specifically, 25-39% have normal IgG levels 2, 3
- Normal globulin levels do NOT exclude AIH and should not dissuade you from pursuing the diagnosis 2
Bilirubin Patterns
- Serum bilirubin is variable, ranging from normal to >20 mg/dL depending on disease severity 1
- In severe cases meeting Hy's Law criteria (AST/ALT >3× ULN plus bilirubin >2× ULN), there is 9-12% risk of death or need for transplantation 1
- Bilirubin elevation is typically less prominent than aminotransferase elevation in chronic presentations 4
Diagnostic Scoring Integration
Revised Original IAIHG Scoring System
The biochemical parameters contribute to diagnosis as follows 1:
- ALP/AST ratio <1.5: +2 points
- Serum globulin or IgG >2.0× ULN: +3 points
- Serum globulin or IgG 1.5-2.0× ULN: +2 points
- Serum globulin or IgG 1.0-1.5× ULN: +1 point
Simplified Scoring System
- IgG >ULN: +1 point 1
- IgG >1.1× ULN: +2 points 1
- Combined with autoantibodies (≥2 points), histology (≥1 point), and negative viral markers (+2 points), a score ≥7 indicates definite AIH and ≥6 indicates probable AIH 1, 2
Monitoring Disease Activity
Serologic Markers for Follow-up
- Both ALT and IgG are most complementary for assessing disease activity 4
- Normalization of both ALT and IgG identifies patients at low risk of fibrosis progression, though about half may still have residual histologic activity (HAI 4-5) 4
- Presence of both elevated ALT and IgG indicates high inflammatory activity (HAI ≥6) with 99% sensitivity 4
- Elevation of either IgG or ALT is associated with residual inflammatory activity in almost all patients 4
Critical Exclusions Required
Before diagnosing AIH based on LFT patterns, you must exclude 3:
- Viral hepatitis (HBV, HCV, HAV, HEV) - check serologic markers 1
- Drug-induced liver injury - detailed medication history including over-the-counter and herbals 1
- Wilson's disease - especially in younger patients; check ceruloplasmin and 24-hour urinary copper 1, 5
- Alcoholic liver disease - alcohol intake history 1
Common Pitfalls to Avoid
- Do not dismiss AIH because globulins are normal - this will miss 15-39% of cases 2
- Do not assume a cholestatic pattern excludes AIH - consider overlap syndromes 1
- Do not rely solely on LFTs - autoantibodies (ANA, SMA ≥1:80 or anti-LKM1 ≥1:40) and liver histology showing interface hepatitis are essential for diagnosis 1, 5, 3
- In COVID-19 patients with AIH, do not presume LFT deterioration as disease flare without biopsy confirmation 1